Human Immunodeficiency Virus  >>  Pegasys (pegylated interferon α -2a)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
DICO, NCT00909129: Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment

Completed
N/A
25
Europe
pegylated interferon-alpha (Pegasys), Pegasys (interferon), ribavirin (COPEGUS), COPEGUS (RIBAVIRIN)
Karolinska Institutet, The Swedish Research Council, Hoffmann-La Roche
Human Immunodeficiency Virus, Chronic Hepatitis C
 
 
NCT00747539: Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

Completed
N/A
330
US
Pegylated interferon alfa and ribavirin (PEG-IFN/RBV), Pegasys
University of California, Los Angeles, National Institute of Mental Health (NIMH)
HIV, Hepatitis C, Infections
06/15
06/15

Download Options